Westfield Capital Management CO LP Vertex Pharmaceuticals Inc Transaction History

Westfield Capital Management CO LP

$21.2 Billion
Q3 2024

A detailed history of Westfield Capital Management CO LP transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Westfield Capital Management CO LP holds 1,272 shares of VRTX stock, worth $638,187. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,272

Previous 544 133.82%

Holding current value

$638,187

Previous $254,000 132.68%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$460.0 - $505.78 $334,880 - $368,207	728 Added 133.82%	1,272 $591,000
Q2 2024 Aug 14, 2024	BUY	$392.81 - $485.53 $213,688 - $264,128	544 New	544 $254,000
Q1 2021 May 14, 2021	SELL	$207.02 - $241.31 $135 Million - $158 Million	-652,910 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$207.01 - $276.09 $11.7 Million - $15.6 Million	56,431 Added 9.46%	652,910 $154 Million
Q3 2020 Nov 13, 2020	BUY	$255.65 - $303.1 $16.1 Million - $19.1 Million	62,901 Added 11.79%	596,479 $162 Million
Q2 2020 Aug 13, 2020	SELL	$225.48 - $295.8 $21.2 Million - $27.8 Million	-93,912 Reduced 14.97%	533,578 $155 Million
Q1 2020 May 14, 2020	SELL	$199.77 - $247.81 $18 Million - $22.3 Million	-90,178 Reduced 12.57%	627,490 $149 Million
Q4 2019 Feb 13, 2020	SELL	$166.71 - $223.91 $35.9 Million - $48.2 Million	-215,080 Reduced 23.06%	717,668 $157 Million
Q3 2019 Nov 08, 2019	BUY	$166.23 - $187.09 $23.5 Million - $26.5 Million	141,428 Added 17.87%	932,748 $158 Million
Q2 2019 Aug 13, 2019	BUY	$164.61 - $190.37 $18 Million - $20.8 Million	109,094 Added 15.99%	791,320 $145 Million
Q1 2019 May 14, 2019	BUY	$163.73 - $194.7 $6.44 Million - $7.66 Million	39,336 Added 6.12%	682,226 $125 Million
Q4 2018 Feb 08, 2019	BUY	$151.91 - $192.21 $14.2 Million - $18 Million	93,461 Added 17.01%	642,890 $107 Million
Q3 2018 Nov 14, 2018	SELL	$167.73 - $192.74 $54.1 Million - $62.1 Million	-322,427 Reduced 36.98%	549,429 $106 Million
Q2 2018 Aug 13, 2018	BUY	$145.72 - $169.96 $13.8 Million - $16.1 Million	94,755 Added 12.19%	871,856 $148 Million
Q1 2018 May 14, 2018	BUY	$151.6 - $177.13 $24 Million - $28 Million	158,240 Added 25.57%	777,101 $127 Million
Q4 2017 Feb 13, 2018	BUY	$137.28 - $155.55 $85 Million - $96.3 Million	618,861	618,861 $92.7 Million

Others Institutions Holding VRTX

# of Institutions

1,717

Shares Held

226M

Call Options Held

1.19M

Put Options Held

1.56M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Westfield Capital Management CO LP, based on Form 13F filings with the SEC.

News

Stay updated on Westfield Capital Management CO LP with notifications on news.

Account

Westfield Capital Management CO LP Vertex Pharmaceuticals Inc Transaction History